Bioelectronics Corp (BIEL)

[kidnova]

You're understanding of the 510K process is faulty. If BIEL is successful in their attempt to get approval for OTC sales via the De Novo process, then anybody with a PEMF device will be able to file a 510K naming BIEL's device as a predicate. BIEL does not have a patent on PEMF in general, just their specific device.

Regardless, as CFM said, this is a pointless debate until it is tested, but I think you are going to be woefully disappointed if you ever expect BIEL to hit a market cap of $100 million, let alone $600 million. At least in the next 10 years or less.